BiondVax Pharmaceuticals Ltd (BVXV)

[Spideyboy]

My desired entry point would be for at most 9 dollars.

While the stock does slide I am curious how the end Q2 data will look like and work to have what effect on the stock price. What are your thoughts on this given the size and the younger, not really flu shot important age of the participants.

Note however 9USD is still a 50% drop from where we are now :) To 90M market cap. Could I be wishing for too much???

Though we have seen a 25% drop since its high less than a month ago, and the stock was at less than 6USD prior to the pandemic, and at 6.5 even after its first pandemic rise and before the confusing article where the professor clearly stated M001 would have no therapeutic value to this pandemic.

Are we expecting the 2019 FY and Q4 financial report pre-end of the month?